Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma, Clear Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01202032
What this trial is testing

Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors

Who this might be right for
Metastatic Renal Cell CarcinomaAdvanced Refractory Solid Tumors Histologically or Cytologically Confirmed
Centre Leon Berard 36
Not applicableStudy completedNCT03748901
What this trial is testing

PD-L1 Expression in Japanese Renal Cell Carcinoma Patients

Who this might be right for
Renal Cell Carcinoma
Chugai Pharmaceutical 830
Testing effectiveness (Phase 2)Ended earlyNCT01806064
What this trial is testing

Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Tracon Pharmaceuticals Inc. 173
Not applicableStudy completedNCT03699579
What this trial is testing

Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC

Who this might be right for
Renal Cell Carcinoma MetastaticRenal Cell Carcinoma
Ipsen 28
Testing effectiveness (Phase 2)Ended earlyNCT00417677
What this trial is testing

A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Wyeth is now a wholly owned subsidiary of Pfizer 124
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06472895
What this trial is testing

AK112 Monotherapy in Advanced/Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Peking University Cancer Hospital & Institute 30
Testing effectiveness (Phase 2)Study completedNCT00830895
What this trial is testing

RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
Seoul National University Hospital 49
Testing effectiveness (Phase 2)Study completedNCT01775930
What this trial is testing

Carfilzomib in Refractory Renal Cell Carcinoma (RCC)

Who this might be right for
Kidney Cancer
M.D. Anderson Cancer Center 10
Early research (Phase 1)Study completedNCT05858736
What this trial is testing

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

Who this might be right for
MelanomaNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+14 more
OncoC4, Inc. 18
Early research (Phase 1)Ended earlyNCT00589550
What this trial is testing

PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Thomas Olencki 1
Early research (Phase 1)Study completedNCT03798626
What this trial is testing

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

Who this might be right for
Colorectal CancerGastroesophageal CancerRenal Cell Carcinoma
Novartis Pharmaceuticals 167
Large-scale testing (Phase 3)Ended earlyNCT03024996
What this trial is testing

Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy

Who this might be right for
Renal Cell Carcinoma
Hoffmann-La Roche 778
Not applicableStudy completedNCT05410509
What this trial is testing

"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"

Who this might be right for
Renal Cell Carcinoma (RCC)
University of Alabama at Birmingham 25
Early research (Phase 1)Study completedNCT03427476
What this trial is testing

CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Cancer Targeted Technology 4
Testing effectiveness (Phase 2)Study completedNCT00444314
What this trial is testing

Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
CASI pharmaceuticals, Inc. 82
Not applicableStudy completedNCT01585974
What this trial is testing

Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Bayer 151
Early research (Phase 1)Looking for participantsNCT04989959
What this trial is testing

[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
Orhan Kemal Oz 35
Early research (Phase 1)Study completedNCT03894618
What this trial is testing

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckMelanomaNon Small Cell Lung Cancer+10 more
Shattuck Labs, Inc. 49
Testing effectiveness (Phase 2)Looking for participantsNCT07223424
What this trial is testing

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

Who this might be right for
Renal Cell CarcinomaNon Small Cell Lung CancerMelanoma+9 more
Diwakar Davar 880
Testing effectiveness (Phase 2)Study completedNCT00591188
What this trial is testing

Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based Regimens

Who this might be right for
Carcinoma, Renal Cell
Kidney Cancer Research Bureau 49
Next Page